Results 121 to 130 of about 934,005 (172)

Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis. [PDF]

Front Endocrinol (Lausanne), 2023
Zhang J, Du M, Zhang C, Wu Y, Guan Y.
europepmc   +1 more source

Comparison of euploidy rates between progestin-primed ovarian stimulation and GnRH antagonist protocols: a single-center study in a mixed-ethnicity population. [PDF]

Front Endocrinol (Lausanne)
Ingold C, Dos Santos GG, Barbosa CP, De Oliveira R.   +3 more
europepmc   +1 more source

Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. [PDF]

Reprod Biol Endocrinol, 2023
Pai AH, Sung YJ, Li CJ, Lin CY, Chang CL.   +4 more
europepmc   +1 more source

Letrozole Co-Administration in Progestin-Primed Ovarian Stimulation (PPOS) Protocols for Patients Undergoing In Vitro Fertilization: A Systematic Review. [PDF]

J Clin Med
Di Girolamo R, Trinchillo MG, Vigilante L, Ordichelli R, Giudice M, Iorio GG, Strina I, Cariati F, Carbone L.   +8 more
europepmc   +1 more source

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study. [PDF]

Front Endocrinol (Lausanne), 2023
Du M, Zhang J, Ren B, Guan Y.
europepmc   +1 more source

ILETIA: An AI-enhanced method for individualized trigger-oocyte pickup interval estimation of progestin-primed ovarian stimulation protocol

In vitro fertilization-embryo transfer (IVF-ET) stands as one of the most prevalent treatments for infertility. During an IVF-ET cycle, the time interval between trigger shot and oocyte pickup (OPU) is a pivotal period for follicular maturation, which ...
Chen, Qiuju, Guo, Haiyan, Zhang, Yuqi, Zhang, Jian, Lu, Xuefeng, Gao, Hongyuan, Feng, Sishuo, Li, Qian, Ren, Qiuhan, Li, Mingyu, Jiang, Yangruizhe, Kuang, Zhe, Wu, Binjian, Zhang, Haicang, Liu, Xinyi, Zha, Jinyin   +15 more
core  

Flexible progestin-primed ovarian stimulation is a safe and effective alternative to GnRH antagonist protocol in PGT-A cycles. [PDF]

Turk J Obstet Gynecol
Turgut NE, Özmen S, Kar E, Benli H, Bastu E.   +4 more
europepmc   +1 more source

Impact of GnRH antagonist protocols versus progestin-primed ovarian stimulation on reproductive outcomes in advanced reproductive age women: a propensity score-matched retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Qi Z, Wang T, Ren J, Zhao S, Song J, Lian F, Zhao Y.   +6 more
europepmc   +1 more source

Correction: A prospective cohort study on progestin-primed ovarian stimulation vs. GnRH antagonist in IVF-ICSI cycles: effects on clinical pregnancy and neonatal outcomes. [PDF]

J Ovarian Res
Yang C, Chen Q, Shen X, Guo H, Lin J, Lu X, Wen X, Zhu Q, Chai W.   +8 more
europepmc   +1 more source

Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation. [PDF]

Reprod Biol Endocrinol
Mathieu d'Argent E, Guivarc'h-Leveque A, Catteau-Jonard S, Cedrin-Durnerin I, Peigné M, Jung C, Goro S, Wang XX, Massin N.   +8 more
europepmc   +1 more source